Literature DB >> 7885425

Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men.

A Ascherio1, E B Rimm, M J Stampfer, E L Giovannucci, W C Willett.   

Abstract

BACKGROUND: It has been hypothesized that a diet containing n-3 fatty acids from fish reduces the risk of coronary heart disease, but few large epidemiologic studies have examined this question.
METHODS: In 1986, 44,895 male health professionals, 40 to 75 years of age, who were free of known cardiovascular disease completed detailed and validated dietary questionnaires as part of the Health Professionals Follow-up Study. During six years of follow-up, we documented 1543 coronary events in this group: 264 deaths from coronary disease, 547 nonfatal myocardial infarctions, and 732 coronary-artery bypass or angioplasty procedures.
RESULTS: After controlling for age and several coronary risk factors, we observed no significant associations between dietary intake of n-3 fatty acids or fish intake and the risk of coronary disease. For men in the top fifth of the group in terms of intake of n-3 fatty acids (median, 0.58 g per day), the multivariate relative risk of coronary heart disease was 1.12 (95 percent confidence interval, 0.96 to 1.31), as compared with the men in the bottom fifth (median, 0.07 g per day). For men who consumed six or more servings of fish per week, as compared with those who consumed one serving per month or less, the multivariate relative risk of coronary disease was 1.14 (95 percent confidence interval, 0.86 to 1.51). The risk of death due to coronary disease among men who ate any amount of fish, as compared with those who ate no fish, was 0.74 (95 percent confidence interval, 0.44 to 1.23), but the risk did not decrease as fish consumption increased.
CONCLUSIONS: Although the possibility of residual confounding by unmeasured factors cannot be entirely excluded, these data suggest that increasing fish intake from one to two servings per week to five to six servings per week does not substantially reduce the risk of coronary heart disease among men who are initially free of cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7885425     DOI: 10.1056/NEJM199504133321501

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  68 in total

Review 1.  Fish oil and omega-3 fatty acids in cardiovascular disease: do they really work?

Authors:  Daan Kromhout; Satoshi Yasuda; Johanna M Geleijnse; Hiroaki Shimokawa
Journal:  Eur Heart J       Date:  2011-09-19       Impact factor: 29.983

Review 2.  Omega 3 fatty acids and cardiovascular disease--fishing for a natural treatment.

Authors:  Jehangir N Din; David E Newby; Andrew D Flapan
Journal:  BMJ       Date:  2004-01-03

Review 3.  From alga to omega; have we reached peak (fish) oil?

Authors:  Paul R Clayton; Szabolcs Ladi
Journal:  J R Soc Med       Date:  2015-09       Impact factor: 5.344

4.  Accelerated solvent extraction for quantitative measurement of fatty acids in plasma and erythrocytes.

Authors:  Kiyonori Kuriki; Kazuo Tajima; Shinkan Tokudome
Journal:  Lipids       Date:  2006-06       Impact factor: 1.880

5.  Fish oil significantly alters fatty acid profiles in various lipid fractions but not atherogenesis in apo E-KO mice.

Authors:  Zuyuan Xu; Natalie Riediger; Sheila Innis; Mohammed H Moghadasian
Journal:  Eur J Nutr       Date:  2007-03       Impact factor: 5.614

Review 6.  Long-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease.

Authors:  Baukje de Roos; Yiannis Mavrommatis; Ingeborg A Brouwer
Journal:  Br J Pharmacol       Date:  2009-05-05       Impact factor: 8.739

7.  Are dietary recommendations for the use of fish oils sustainable?

Authors:  David J A Jenkins; John L Sievenpiper; Daniel Pauly; Ussif Rashid Sumaila; Cyril W C Kendall; Farley M Mowat
Journal:  CMAJ       Date:  2009-03-17       Impact factor: 8.262

Review 8.  n-3 fatty acids and lipoproteins: comparison of results from human and animal studies.

Authors:  W S Harris
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

Review 9.  New approaches to therapy with omega-3 fatty acids.

Authors:  Puneet Kakar; Timothy Watson; Gregory Y H Lip
Journal:  Curr Atheroscler Rep       Date:  2008-02       Impact factor: 5.113

Review 10.  Dyslipidemia in patients with chronic and end-stage kidney disease.

Authors:  Jad Omran; Ashraf Al-Dadah; Kevin C Dellsperger
Journal:  Cardiorenal Med       Date:  2013-07-13       Impact factor: 2.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.